Inhibrx Biosciences, Inc. (INBX)

73.85 +0.95 (+1.30%) USD  |  NASDAQ  |  Jan 21, 10:42
More

Inhibrx Biosciences EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for INBX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Agenus, Inc. Upgrade
Ligand Pharmaceuticals, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade
Adverum Biotechnologies, Inc. Upgrade
Pelthos Therapeutics, Inc. Upgrade